Potential COVID-19 vaccine produced at Catalent’s Madison facility

Catalent, Inc.’s biomanufacturing facility in Madison.
Catalent, Inc.’s biomanufacturing facility in Madison.
As researchers race to develop a vaccine for COVID-19, production on one potential single-shot vaccine is underway at Catalent, Inc.’s biomanufacturing facility in Madison. Somerset, New Jersey-based Catalent and San Diego-based Arcturus Therapeutics Holdings Inc.…

Want to Read More?

Paid BizTimes subscribers get unlimited access to all Insider content and much more. Learn more in our Insider FAQ.

Become an Insider Now

Already an Insider? Log In

Or click here to purchase a paywall bypass link for this article.

Sign up for BizTimes Daily Alerts

Stay up-to-date on the people, companies and issues that impact business in Milwaukee and Southeast Wisconsin

Lauren Anderson is an associate editor and covers health care, nonprofits and education for BizTimes. Lauren previously reported on education for the Waukesha Freeman. She graduated from the University of Wisconsin-Madison, where she studied journalism.

No posts to display